{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:03:23Z","timestamp":1777935803690,"version":"3.51.4"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":3565,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Emmie's Fund for Respiratory Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Canine chronic bronchitis (CCB) results in cough lasting \u22652 months and airway inflammation. Adverse effects include risk of secondary infection associated with lifelong corticosteroid administration and prompt investigation into alternative therapies. Neurogenic pathways mediated by tachykinins that bind neurokinin (NK) 1 receptors may induce cough and airway inflammation. Maropitant,a a NK-1 receptor antagonist, has been advocated for treatment of CCB based on anecdotal improvement, but without scientific evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>Maropitanta will blunt clinical signs and airway inflammation associated with CCB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Client-owned dogs (n = 8) with cough &amp;gt;2 months, thoracic radiographic evidence of airway disease and sterile airway inflammation (&amp;gt;7% non-degenerate neutrophils, &amp;gt;7% eosinophils or both) on bronchoalveolar lavage (BAL) enrolled.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Maropitanta (2 mg\/kg) administered q48h for 14 days. Study endpoints included client perception of clinical signs (surveys at baseline and 14 days, and visual analogue scale [VAS] at baseline, 7, and 14 days), and BAL % neutrophils and eosinophils (baseline and 14 days). One-way repeated measures ANOVA (VAS) and Wilcoxon-signed rank-sum tests (BAL cells, cough frequency) used with P &amp;lt; .05 considered significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Maropitanta significantly decreased cough frequency (P &amp;lt; .001) and VAS scores (P = .005). No differences in BAL % neutrophils or % eosinophils noted with treatment (P = .279 and P = .382, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Preliminary results suggest that although maropitanta may have antitussive properties leading to perceived clinical improvement, its failure to diminish airway inflammation makes it unsuitable for treatment of CCB. Future studies could evaluate maropitanta as a cough suppressant for other respiratory disorders in dogs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.13935","type":"journal-article","created":{"date-parts":[[2016,3,20]],"date-time":"2016-03-20T15:52:42Z","timestamp":1458489162000},"page":"847-852","source":"Crossref","is-referenced-by-count":19,"title":["Investigation of Neurokinin-1 Receptor Antagonism as a Novel Treatment for Chronic Bronchitis in Dogs"],"prefix":"10.1093","volume":"30","author":[{"given":"M.","family":"Grobman","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, University of Missouri Department of Veterinary Medicine and Surgery, , Columbia, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Reinero","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, University of Missouri Department of Veterinary Medicine and Surgery, , Columbia, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,5,1]]},"reference":[{"key":"2026020304515355700_jvim13935-bib-0001","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0195-5616(00)06006-X","article-title":"Diagnosis and treatment of canine chronic bronchitis. Twenty years of experience","volume":"30","author":"McKiernan","year":"2000","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020304515355700_jvim13935-bib-0002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cvsm.2013.09.005","article-title":"Canine chronic bronchitis","volume":"44","author":"Rozanski","year":"2014","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020304515355700_jvim13935-bib-0003","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1939-1676.2010.0530.x","article-title":"Demographic and historical findings, including exposure to environmental tobacco smoke, in dogs with chronic cough","volume":"24","author":"Hawkins","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020304515355700_jvim13935-bib-0004","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2174\/138945006778019318","article-title":"Tachykinins in the respiratory tract","volume":"7","author":"Groneberg","year":"2006","journal-title":"Curr Drug Targets"},{"key":"2026020304515355700_jvim13935-bib-0005","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1183\/09031936.95.08071193","article-title":"Neurophysiology of the cough reflex","volume":"8","author":"Widdicombe","year":"1995","journal-title":"Eur Respir J"},{"key":"2026020304515355700_jvim13935-bib-0006","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1164\/rccm.200308-1139OC","article-title":"Passive smoke effects on cough and airways in young guinea pigs: Role of brainstem substance P","volume":"169","author":"Joad","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2026020304515355700_jvim13935-bib-0007","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1113\/jphysiol.2003.051326","article-title":"Substance P presynaptically depresses the transmission of sensory input to bronchopulmonary neurons in the guinea pig nucleus tractus solitarii","volume":"552","author":"Sekizawa","year":"2003","journal-title":"J Physiol"},{"key":"2026020304515355700_jvim13935-bib-0008","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0014-2999(00)00763-9","article-title":"Role of substance P and tachykinin receptor antagonists in citric acid-induced cough in pigs","volume":"408","author":"Moreaux","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"2026020304515355700_jvim13935-bib-0009","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000330419","article-title":"Plasma substance P levels in patients with persistent cough","volume":"82","author":"Otsuka","year":"2011","journal-title":"Respiration"},{"key":"2026020304515355700_jvim13935-bib-0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcp.20061","article-title":"The role of substance P in inflammatory disease","volume":"201","author":"O'Connor","year":"2004","journal-title":"J Cell Physiol"},{"issue":"3","key":"2026020304515355700_jvim13935-bib-0011","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1628","article-title":"Evidence for substance P as an endogenous substance causing cough in guinea pigs","volume":"148","author":"Ujiie","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"2026020304515355700_jvim13935-bib-0012","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejphar.2003.11.048","article-title":"Antitussive activity of the tachykinin NK1 receptor antagonist, CP-99994, in dogs","volume":"485","author":"Chapman","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"2026020304515355700_jvim13935-bib-0013","article-title":"Chronic neurokinin-1 receptor antagonism fails to ameliorate clinical signs, airway hyper-responsiveness or airway eosinophilia in an experimental model of feline asthma","volume-title":"J Feline Med Surg","author":"Grobman","year":"2015"},{"key":"2026020304515355700_jvim13935-bib-0014","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1164\/rccm.200608-1186OC","article-title":"Effect of an NK1\/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma","volume":"175","author":"Boot","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020304515355700_jvim13935-bib-0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-2999(01)01323-1","article-title":"Airway inflammation and tachykinins: Prospects for the development of tachykinin receptor antagonists","volume":"429","author":"Joos","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"2026020304515355700_jvim13935-bib-0016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1939-1676.1990.tb03120.x","article-title":"Bronchoalveolar lavage in the evaluation of pulmonary disease in the dog and cat","volume":"4","author":"Hawkins","year":"1990","journal-title":"J Vet Intern Med"},{"key":"2026020304515355700_jvim13935-bib-0017","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1096-2867(99)80014-0","article-title":"Collection and interpretation of respiratory cytology","volume":"14","author":"McCullough","year":"1999","journal-title":"Clin Tech in Small Anim Pract"},{"key":"2026020304515355700_jvim13935-bib-0018","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/cea.12411","article-title":"Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma","volume":"44","author":"Trzil","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"2026020304515355700_jvim13935-bib-0019","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2885.2007.00877.x","article-title":"The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs","volume":"30","author":"Benchaoui","year":"2007","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020304515355700_jvim13935-bib-0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1748-5827.2006.00321.x","article-title":"The anti-emetic efficacy of maropitant (Cerenia\u2122) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe","volume":"48","author":"De la Puente-Redondo","year":"2007","journal-title":"J Small Anim Pract"},{"key":"2026020304515355700_jvim13935-bib-0021","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/jappl.1999.86.3.1017","article-title":"Influence of central antitussive drugs on the cough motor pattern","volume":"86","author":"Bolser","year":"1999","journal-title":"J Appl Physiol"},{"issue":"3","key":"2026020304515355700_jvim13935-bib-0022","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1113\/jphysiol.1996.sp021378","article-title":"Substance P contributes to rapidly adapting receptor responses to pulmonary venous congestion in rabbits","volume":"493","author":"Bonham","year":"1996","journal-title":"J Physiol"},{"key":"2026020304515355700_jvim13935-bib-0023","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0091-6749(03)01784-6","article-title":"Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin","volume":"112","author":"Cho","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"2026020304515355700_jvim13935-bib-0024","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjp.0701111","article-title":"Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat","volume":"121","author":"Bolser","year":"1997","journal-title":"Br J Pharmacol"},{"key":"2026020304515355700_jvim13935-bib-0025","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1378\/chest.14-1481","article-title":"Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report","volume":"146","author":"Canning","year":"2014","journal-title":"Chest"},{"key":"2026020304515355700_jvim13935-bib-0026","first-page":"39","article-title":"Placebo effect and placebo concept: A critical methodological and conceptual analysis of reports on the magnitude of the placebo effect","volume":"2","author":"Kienle","year":"1996","journal-title":"Altern Ther Health Med"},{"key":"2026020304515355700_jvim13935-bib-0027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2466-11-41","article-title":"Tachykinin receptors antagonism for asthma: A systematic review","volume":"11","author":"Ramalho","year":"2011","journal-title":"BMC Pulm Med"},{"key":"2026020304515355700_jvim13935-bib-0028","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.4049\/jimmunol.158.8.3895","article-title":"Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells","volume":"158","author":"Schratzberger","year":"1997","journal-title":"J Immunol"},{"key":"2026020304515355700_jvim13935-bib-0029","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000080654","article-title":"An experimental model of allergic asthma in cats sensitized to house dust mite or bermuda grass allergen","volume":"135","author":"Norris Reinero","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"key":"2026020304515355700_jvim13935-bib-0030","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1164\/ajrccm.155.5.9154886","article-title":"Effects of neurokinin depletion on airway inflammation induced by chronic antigen exposure","volume":"155","author":"Tiberio","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020304515355700_jvim13935-bib-0031","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1183\/09031936.93.04060673","article-title":"Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics","volume":"4","author":"Ollerenshaw","year":"1991","journal-title":"Eur Respir J"},{"key":"2026020304515355700_jvim13935-bib-0032","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0306-4522(88)90330-2","article-title":"Co-localization of vasoactive intestinal peptide- and substance P-containing nerves in cat bronchi","volume":"24","author":"Dey","year":"1988","journal-title":"Neuroscience"},{"key":"2026020304515355700_jvim13935-bib-0033","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2885.2008.00992.x","article-title":"Safety and efficacy of injectable and oral maropitant, a selective neurokinin1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs","volume":"31","author":"Ramsey","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020304515355700_jvim13935-bib-0034","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000096078","article-title":"Prednisone blunts airway neutrophilic inflammatory response due to ozone exposure in asthmatic subjects","volume":"74","author":"Vagaggini","year":"2007","journal-title":"Respiration"},{"key":"2026020304515355700_jvim13935-bib-0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/15412550802363360","article-title":"Anti-inflammatory effects of combined budesonide\/formoterol in COPD exacerbations","volume":"5","author":"Bathoorn","year":"2008","journal-title":"COPD"},{"key":"2026020304515355700_jvim13935-bib-0036","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2460\/ajvr.2005.66.1121","article-title":"Effects of drug treatment on inflammation and hyperreactivity of airways and on immune variables in cats with experimentally induced asthma","volume":"66","author":"Reinero","year":"2005","journal-title":"Am J Vet Res"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.13935","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.13935","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.13935","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/30\/3\/847\/66695323\/jvim13935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/30\/3\/847\/66695323\/jvim13935.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:52:05Z","timestamp":1770112325000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/30\/3\/847\/8452799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.13935","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,5]]},"published":{"date-parts":[[2016,5,1]]}}}